Updated guidelines, online assessment tool, and new therapies coming this year
Search results for: vertebral fracture
Drug Updates: Information on New Approvals and Medication Safety
Information on New Approvals and Medication Safety
Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?
Handpicked Reviews of Contemporary Literature
Build Up Bone
Current management of osteoporosis
Reading Rheum
Handpicked Reviews of Contemporary Literature
Coding Changes for 2007
Note these CPT and Healthcare Common Procedure Coding System (HCPCS) code changes…
What Has the ACR Done for You Lately?
The world in which we currently practice is not the same one we knew five to 10 years ago. Insurers second-guess our decisions and create numerous hurdles for us to overcome before our patients can be treated. Government agencies are seeking ways to reduce healthcare expenditures and improve what they perceive as a lack of quality and consistency in healthcare delivery. These groups, as well as Congress and employers (who purchase benefits for their employees), have begun a concerted effort to grade rheumatologists on the basis of what they perceive to be quality and efficiency and then pay us according to those criteria.
Reading RHEUM
Handpicked Reviews of Contemporary Literature
Case Report: Giant Cell Arteritis-Related Stroke
Thromboembolic events are major contributors to the morbidity and mortality of patients with giant cell arteritis (GCA), but little is known about how GCA may increase the risk of ischemic strokes. GCA-related stroke is described as an ischemic cerebral infarct occurring within three to four weeks of GCA diagnosis and treatment. It occurs in 3–7%…
Untangling the Diagnosis & Management of GCA
Vision loss, implications of treatment and more—Sarah Mackie, BMBCh, PhD, MRCP, discussed the latest research on the evaluation and management of giant cell arteritis.
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- Next Page »